Can You Take NMN with Metformin? Interaction Evidence
NMN with metformin has limited direct human evidence. What the studies establish about safety, proposed synergy, exercise and medication timing.
Updated
3 min read · 10 sources
On this page
If you take metformin for diabetes or another prescribed reason and are considering NMN, the main limitation is the evidence for using them together. The studies reviewed here do not establish the combination's safety or added clinical benefit. Findings from an NMN-only trial or a metabolic pathway cannot answer that question.
For the underlying glucose-control question, our NMN and diabetes evidence review distinguishes muscle insulin-sensitivity findings from established diabetes treatment benefits.
Featured partner
CoreAge Rx
From $93/mo
Check availabilityRead our reviewAffiliate link. We may earn a commission at no extra cost to you.
Affiliate partner
MadeMed
NAD+ injection & nasal spray, in 23 states
See MadeMedWhat do human studies establish about the combination?
Metformin and NMN have different roles in metabolism. Metformin has several glucose-lowering actions 1. NMN is a precursor to NAD+; an 80-person trial in healthy middle-aged adults found higher blood NAD+ during 60 days of supplementation and reported no safety issues within its study conditions 2. That trial was not a dedicated NMN–metformin interaction study. Our NMN side-effect guide explains why short-term tolerability does not establish safety for every patient or medication combination.
An absence of a documented interaction does not establish that a combination is safe. Ask the clinician who manages your metformin to review the exact NMN product, other medicines and medical history before adding it. Metformin's own monitoring requirements, including kidney function and vitamin B12, still apply 10. The B12 guide separates evaluation of a nutrient problem from adding an NAD+ product for general wellness.
Where they converge
Metformin
Activates AMPK (energy sensor)
NMN → NAD+
Fuels sirtuin enzymes
AMPK ↔ sirtuin cross-talk
Theoretical synergy — unproven in trials
Why a shared pathway does not prove synergy
Metformin can affect AMPK-related signaling, while NMN contributes to NAD+ metabolism 12. Those mechanisms motivate a hypothesis about combining them. Demonstrating synergy would require a suitable human comparison of the combination with its individual components; a pathway diagram cannot supply that comparison.
The cited studies do not establish a clinical benefit from adding NMN to metformin. Metformin's proposed use for healthspan extension is also distinct from its prescribed clinical use 7. A systematic review found no significant NMN benefit for skeletal muscle index, handgrip strength, gait speed or chair-stand performance in adults with a mean age above 60 3. Another review, covering eight short trials in 342 mainly nondiabetic adults, found no significant pooled benefit for the measured glucose or lipid markers 4. These findings have defined populations and outcomes; they do not establish that every NMN effect is absent. Individual trials have reported selected functional or insulin-sensitivity findings 28, without demonstrating NMN–metformin synergy.
Metformin and exercise: findings depend on the study
Some trials in older adults found that metformin reduced selected training adaptations. A 12-week aerobic study reported smaller gains in insulin sensitivity and cardiorespiratory fitness and less improvement in muscle mitochondrial respiration; several other exercise benefits remained 5. The MASTERS trial found smaller gains in lean mass and thigh muscle measures during resistance training, while the difference in strength gains did not reach statistical significance 9. Its later transcriptomic analysis explored possible mechanisms 6. These findings do not establish one proven explanation for every exercise response.
Neither trial tested NMN as a way to prevent the observed effects of metformin on training. They also do not show that everyone taking prescribed metformin should stop it or change their exercise plan. The reason for the prescription, glucose control and individual response belong in a discussion with the treating clinician.
What's actually known
- Established NMN–metformin safetyNone evidence
The cited studies do not establish safety of the combination.
- NMN + metformin synergy (any clinical outcome)None evidence
Added clinical benefit is not established by the cited studies.
- Metformin blunts exercise adaptation (older adults)Moderate evidence
Randomized trials: reduced aerobic and resistance-training gains.
- NMN raises blood NAD+Strong evidence
Replicated, dose-dependent — but a biomarker, not an outcome.
What about taking them at the same time?
The sources reviewed here do not establish an NMN–metformin spacing interval. The exercise trials above compared metformin with placebo during training; they did not establish a medication schedule that prevents reduced training adaptations 59. Follow the instructions for the prescribed metformin formulation, including its meal directions, and discuss timing changes with the prescriber 10.
So should you stack them?
If you already take metformin, adding NMN is a separate decision with uncertain benefit and limited direct combination evidence. Short NMN studies cannot establish safety for all metformin users. Review the exact product and treatment goal with the prescriber, and do not change a prescribed medicine to accommodate a supplement.
Bottom line
The studies reviewed here do not establish that NMN with metformin is safe or more effective than either intervention alone. Exercise findings from particular metformin trials do not supply a timing workaround or a reason to change a prescription without clinical review. For how far NMN's own evidence actually reaches, see does NMN actually work?; for the other popular co-ingredient, see the NMN + TMG stack; for dosing context, the NAD+ dosage guide; for the broader medication picture beyond metformin, see NMN and medications: interactions you should know; and for the candid case against the whole regimen, why people stop taking NMN. The broader category sits in our NAD+ therapy evidence pillar and our NAD+ rankings hub.
Frequently asked questions
Is it safe to take NMN with metformin?
The sources reviewed here do not establish the combination's safety. Short NMN studies and a lack of documented interaction reports cannot answer the question for every metformin user. Have the prescribing clinician review the exact product, other medicines and medical history before adding it.
Do NMN and metformin work synergistically?
A proposed connection between metabolic pathways is not a demonstrated clinical result. The cited human studies do not establish that adding NMN to metformin improves health outcomes or is safer than either intervention alone.
Does metformin interfere with NMN's effects?
The cited studies do not establish whether metformin changes NMN’s effects. Some trials in older adults found smaller improvements in selected training outcomes with metformin, but they did not test an NMN interaction or establish a reason to stop prescribed treatment.
Should I separate the timing of NMN and metformin?
No validated spacing interval is established by the sources reviewed here. The exercise-adaptation trials do not show that changing metformin timing prevents their findings. Follow the prescription’s instructions and discuss medication or supplement timing with the prescriber.
References
- Rena G, Hardie DG, Pearson ER (2017). The mechanisms of action of metformin. Diabetologia. https://pubmed.ncbi.nlm.nih.gov/28776086/
- Yi L, Maier AB, Tao R, et al. (2023). The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. https://pubmed.ncbi.nlm.nih.gov/36482258/
- Prokopidis K, Moriarty F, Bahat G, et al. (2025). The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis. Journal of Cachexia, Sarcopenia and Muscle. https://pubmed.ncbi.nlm.nih.gov/40275690/
- Chen F, et al. (2024). Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials. Current Diabetes Reports. https://pubmed.ncbi.nlm.nih.gov/39531138/
- Konopka AR, Laurin JL, Schoenberg HM, et al. (2019). Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults. Aging Cell. https://pubmed.ncbi.nlm.nih.gov/30548390/
- Kulkarni AS, Peck BD, Walton RG, et al. (2020). Metformin alters skeletal muscle transcriptome adaptations to resistance training in older adults. Aging (Albany NY). https://pubmed.ncbi.nlm.nih.gov/33071237/
- Espinoza SE, Khosla S, Baur JA, et al. (2023). Drugs Targeting Mechanisms of Aging to Delay Age-Related Disease and Promote Healthspan: Proceedings of a National Institute on Aging Workshop. The Journals of Gerontology: Series A. https://pubmed.ncbi.nlm.nih.gov/37325957/
- Yoshino M, Yoshino J, Kayser BD, Klein S, et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. https://pubmed.ncbi.nlm.nih.gov/33888596/
- Walton RG, Dungan CM, Long DE, et al. (2019). Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults: A randomized, double-blind, placebo-controlled, multicenter trial: The MASTERS trial. Aging Cell. https://pubmed.ncbi.nlm.nih.gov/31557380/
- U.S. Food and Drug Administration (2018). GLUCOPHAGE and GLUCOPHAGE XR: prescribing information. FDA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020357s034,021202s018lbl.pdf
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Related reading
NMN & NAD+ for Kidney Health (CKD): What's Proven?
Human NR trials in CKD and acute kidney injury measured metabolism, exercise and safety. None establishes NMN as a treatment that preserves kidney function.
ReadNMN and Medications: Interactions You Should Know
NMN interaction data is limited. What short-term trials establish, why niacin warnings differ, and how medicines and blend ingredients change the assessment.
ReadNMN Side Effects: What the Human Studies Actually Show
NMN studies offer short-term tolerability data, not proof of long-term safety. Understand the study limits, product quality and questions for your clinician.
ReadNAD+ and Methylene Blue: Evidence, Interactions and Risks
Does combining NAD+ with methylene blue improve energy or cognition? What human studies show, where FDA approval applies, and why medication review matters.
ReadNAD+, NMN and NR During Pregnancy and Breastfeeding
What is known about NAD+, NMN and NR in pregnancy and breastfeeding—and why fertility studies and vitamin B3 nutrition do not establish safety.
ReadNMN for Diabetes: Insulin Sensitivity and Blood Sugar Evidence
What human NMN studies show about insulin sensitivity, glucose and HbA1c—and why a prediabetes signal is not a diabetes treatment.
Read